CAR T-Cell Therapy for Relapsed/Refractory CLL
2 Visualizzazioni
• 07/14/23
0
0
Incorporare
administrator
Iscritti
The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti